These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30170320)

  • 81. 1,2,3-Triazolyl-4-oxoquinolines: A feasible beginning for promising chemical structures to inhibit oseltamivir-resistant influenza A and B viruses.
    Boechat Fda C; Sacramento CQ; Cunha AC; Sagrillo FS; Nogueira CM; Fintelman-Rodrigues N; Santos-Filho O; Riscado CS; Forezi Lda S; Faro LV; Brozeguini L; Marques IP; Ferreira VF; Souza TM; de Souza MC
    Bioorg Med Chem; 2015 Dec; 23(24):7777-84. PubMed ID: 26643220
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Synthesis and anti-influenza virus activity of 7-O-alkylated derivatives related to zanamivir.
    Honda T; Masuda T; Yoshida S; Arai M; Kaneko S; Yamashita M
    Bioorg Med Chem Lett; 2002 Aug; 12(15):1925-8. PubMed ID: 12113810
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Novel cycloalkylthiophene-imine derivatives bearing benzothiazole scaffold: synthesis, characterization and antiviral activity evaluation.
    Ke S; Wei Y; Yang Z; Wang K; Liang Y; Shi L
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5131-4. PubMed ID: 23920438
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Wogonin, a flavonoid isolated from Scutellaria baicalensis, has anti-viral activities against influenza infection via modulation of AMPK pathways.
    Seong RK; Kim JA; Shin OS
    Acta Virol; 2018; 62(1):78-85. PubMed ID: 29521106
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Evaluation of the in-vitro activity of the glycopeptide antibiotic LY333328 in comparison with vancomycin and teicoplanin.
    Harland S; Tebbs SE; Elliott TS
    J Antimicrob Chemother; 1998 Feb; 41(2):273-6. PubMed ID: 9533471
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Spiro[pyrrolidine-2,2'-adamantanes]: synthesis, anti-influenza virus activity and conformational properties.
    Stylianakis I; Kolocouris A; Kolocouris N; Fytas G; Foscolos GB; Padalko E; Neyts J; De Clercq E
    Bioorg Med Chem Lett; 2003 May; 13(10):1699-703. PubMed ID: 12729645
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Design of inhibitors of influenza virus membrane fusion: synthesis, structure-activity relationship and in vitro antiviral activity of a novel indole series.
    Brancato V; Peduto A; Wharton S; Martin S; More V; Di Mola A; Massa A; Perfetto B; Donnarumma G; Schiraldi C; Tufano MA; de Rosa M; Filosa R; Hay A
    Antiviral Res; 2013 Aug; 99(2):125-35. PubMed ID: 23707194
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Anti-influenza virus activity and structure-activity relationship of aglycoristocetin derivatives with cyclobutenedione carrying hydrophobic chains.
    Naesens L; Vanderlinden E; Roth E; Jeko J; Andrei G; Snoeck R; Pannecouque C; Illyés E; Batta G; Herczegh P; Sztaricskai F
    Antiviral Res; 2009 Apr; 82(1):89-94. PubMed ID: 19200809
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Synthesis and antiviral activity of conformational analogues of leucamide A.
    Wang WL; Chen HJ; Ma WP; Gu M; Fan MZ; Li JY; Feng B; Nan FJ
    Molecules; 2012 Dec; 17(12):14522-30. PubMed ID: 23222900
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Synthesis, antiviral activity, preliminary pharmacokinetics and structural parameters of thiazolide amine salts.
    Stachulski AV; Rossignol JF; Pate S; Taujanskas J; Robertson CM; Aerts R; Pascal E; Piacentini S; Frazia S; Santoro MG; O'Neill PM
    Future Med Chem; 2021 Oct; 13(20):1731-1741. PubMed ID: 34402654
    [No Abstract]   [Full Text] [Related]  

  • 91. Two Novel Semisynthetic Lipoglycopeptides Active against
    Vimberg V; Zieglerova L; Mazumdar A; Szűcs Z; Borbás A; Herczegh P; Novotna GB
    Pharmaceuticals (Basel); 2021 Nov; 14(11):. PubMed ID: 34832964
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The First Dimeric Derivatives of the Glycopeptide Antibiotic Teicoplanin.
    Bereczki I; Szűcs Z; Batta G; Nagy TM; Ostorházi E; Kövér KE; Borbás A; Herczegh P
    Pharmaceuticals (Basel); 2022 Jan; 15(1):. PubMed ID: 35056134
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Hydrophobic Derivatives of Glycopeptide Antibiotics as Inhibitors of Protein Kinases.
    Cozza G; Fortuna M; Meggio F; Sarno S; Kubbutat MHG; Totzke F; Schaechtele C; Pinna LA; Olsufyeva EN; Preobrazhenskaya MN
    Biochemistry (Mosc); 2018 Oct; 83(10):1222-1230. PubMed ID: 30472959
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Mucin biopolymers as broad-spectrum antiviral agents.
    Lieleg O; Lieleg C; Bloom J; Buck CB; Ribbeck K
    Biomacromolecules; 2012 Jun; 13(6):1724-32. PubMed ID: 22475261
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Asymmetric catalysis at a distance: catalytic, site-selective phosphorylation of teicoplanin.
    Han S; Miller SJ
    J Am Chem Soc; 2013 Aug; 135(33):12414-21. PubMed ID: 23924210
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Amphiphilic Sialic Acid Derivatives as Potential Dual-Specific Inhibitors of Influenza Hemagglutinin and Neuraminidase.
    Lőrincz EB; Herczeg M; Houser J; Rievajová M; Kuki Á; Malinovská L; Naesens L; Wimmerová M; Borbás A; Herczegh P; Bereczki I
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139095
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Semisynthetic teicoplanin derivatives with dual antimicrobial activity against SARS-CoV-2 and multiresistant bacteria.
    Bereczki I; Vimberg V; Lőrincz E; Papp H; Nagy L; Kéki S; Batta G; Mitrović A; Kos J; Zsigmond Á; Hajdú I; Lőrincz Z; Bajusz D; Petri L; Hodek J; Jakab F; Keserű GM; Weber J; Naesens L; Herczegh P; Borbás A
    Sci Rep; 2022 Sep; 12(1):16001. PubMed ID: 36163239
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Recent Advances in the Development of Semisynthetic Glycopeptide Antibiotics: 2014-2022.
    van Groesen E; Innocenti P; Martin NI
    ACS Infect Dis; 2022 Aug; 8(8):1381-1407. PubMed ID: 35895325
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Teicoplanin-A New Use for an Old Drug in the COVID-19 Era?
    Vimberg V
    Pharmaceuticals (Basel); 2021 Nov; 14(12):. PubMed ID: 34959628
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.